Clinical trial
An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease
NCT00514813 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label, Phase IV, Multi-Centre Study to Investigate the Long-Term Safety and Efficacy of Subcutaneous Dynepo in Adult Patients With Anaemia Associated With Chronic Kidney Disease
- Lead sponsor
- Shire
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 6, 2007
- Completion date
- July 31, 2008
- Enrollment
- 152 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.